Cite
HARVARD Citation
Seifert, H. et al. (n.d.). 2763 Poor performance status (PS) is an indication for an aggressive approach to neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer (EOC). European journal of cancer. pp. S551-S552. [Online].